BN Business News
Add your company to Business Communicator →

Energy & environment · 09/06/2006Updated: 10/17/2026 · 1 min read

Fox Chase Cancer Center Facility in Philadelphia, PA to be Released from Byproduct Materials License Restrictions

Summary

The U.S. Nuclear Regulatory Commission (NRC) has made a Finding of No Significant Impact (FONSI) for the unrestricted release of a Fox Chase Cancer Center facility in Philadelphia, PA, following an Environmental Assessment for License Amendment to Byproduct Materials License No. 37-02766-01.

Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →

Explore insights

Business insights →